biote Corp. (BTMD)
biote Statistics
Share Statistics
biote has 54.71M shares outstanding. The number of shares has increased by -11.81% in one year.
| Shares Outstanding | 54.71M |
| Shares Change (YoY) | -11.81% |
| Shares Change (QoQ) | 0.69% |
| Owned by Institutions (%) | 60.55% |
| Shares Floating | 49.96M |
| Failed to Deliver (FTD) Shares | 1.26K |
| FTD / Avg. Volume | 0.64% |
Short Selling Information
The latest short interest is 782.67K, so 1.44% of the outstanding shares have been sold short.
| Short Interest | 782.67K |
| Short % of Shares Out | 1.44% |
| Short % of Float | 1.57% |
| Short Ratio (days to cover) | 6.82 |
Valuation Ratios
The PE ratio is 67.09 and the forward PE ratio is 6.17. biote's PEG ratio is -2.3.
| PE Ratio | 67.09 |
| Forward PE | 6.17 |
| PS Ratio | 1.07 |
| Forward PS | 0.8 |
| PB Ratio | -2.07 |
| P/FCF Ratio | 5.46 |
| PEG Ratio | -2.3 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for biote.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of -0.09.
| Current Ratio | 1.32 |
| Quick Ratio | 1.03 |
| Debt / Equity | -0.09 |
| Debt / EBITDA | 0.62 |
| Debt / FCF | 0.25 |
| Interest Coverage | 2.87 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $908.71K |
| Profits Per Employee | $14.55K |
| Employee Count | 217 |
| Asset Turnover | 1.61 |
| Inventory Turnover | 3.92 |
Taxes
| Income Tax | 970K |
| Effective Tax Rate | 95.47% |
Stock Price Statistics
The stock price has increased by -37.26% in the last 52 weeks. The beta is 1.07, so biote's price volatility has been higher than the market average.
| Beta | 1.07 |
| 52-Week Price Change | -37.26% |
| 50-Day Moving Average | 4.51 |
| 200-Day Moving Average | 5.83 |
| Relative Strength Index (RSI) | 41.6 |
| Average Volume (20 Days) | 198.42K |
Income Statement
In the last 12 months, biote had revenue of 197.19M and earned 3.16M in profits. Earnings per share was 0.09.
| Revenue | 197.19M |
| Gross Profit | 139.06M |
| Operating Income | 31.61M |
| Net Income | 3.16M |
| EBITDA | 15.59M |
| EBIT | 12.02M |
| Earnings Per Share (EPS) | 0.09 |
Balance Sheet
The company has 39.34M in cash and 9.66M in debt, giving a net cash position of 29.68M.
| Cash & Cash Equivalents | 39.34M |
| Total Debt | 9.66M |
| Net Cash | 29.68M |
| Retained Earnings | -100.3M |
| Total Assets | 122.37M |
| Working Capital | 16.61M |
Cash Flow
In the last 12 months, operating cash flow was 45.24M and capital expenditures -6.43M, giving a free cash flow of 38.81M.
| Operating Cash Flow | 45.24M |
| Capital Expenditures | -6.43M |
| Free Cash Flow | 38.81M |
| FCF Per Share | 1.13 |
Margins
Gross margin is 70.52%, with operating and profit margins of 16.03% and 1.6%.
| Gross Margin | 70.52% |
| Operating Margin | 16.03% |
| Pretax Margin | 0.52% |
| Profit Margin | 1.6% |
| EBITDA Margin | 7.91% |
| EBIT Margin | 16.03% |
| FCF Margin | 19.68% |
Dividends & Yields
BTMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for BTMD is $8, which is 121% higher than the current price. The consensus rating is "Buy".
| Price Target | $8 |
| Price Target Difference | 121% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 1.29 |
| Piotroski F-Score | 8 |